Cold Pain Therapy Market Dominated by (Musculoskeletal Disorders, Post-Operative Therapy, Sports Medicine and Post-Trauma Therapy) Applications

OTC products segment accounted for larger share of global cold pain therapy market in 2017. This can be attributed to factors such as high patient preference for topical pharmaceuticals compared to oral medications owing to its lower side effects, fast pain relief, and convenience in use.

Cold pain therapy market is projected to reach USD 2.12 billion by 2023 from USD 1.69 billion in 2018, at a CAGR of 4.6%. Increasing incidence of sports injuries & rising emphasis on exercise and gym activities, growing number of hip & knee surgeries across globe & growing need for safer pain management modalities as opposed to oral drug therapy are expected to drive the demand. Get Free Market Updates Now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=725677 .

The various product segments considered in cold pain therapy market was dominated by Sanofi (France), DJO Finance (US), and Pfizer (US). These companies accounted for a majority share of the global market in 2017. The other players involved in this market include 3M (US), Hisamitsu Pharmaceutical (Japan), Johnson & Johnson (US), Medline Industries (US), Össur (Iceland), Performance Health (US), Beiersdorf (Germany), Rohto Pharmaceutical (US), Breg (US), Romsons Group of Industries (India), Custom Ice (US), and Unexo Life Sciences (India).

Objectives of the study are:
• To define, describe, and forecast the global cold pain therapy market by product, application, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the total market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the revenue of the market segments with respect to four main regions, namely, North America (US & Canada), Europe (Germany, UK, France, Italy, Spain, and RoE), Asia Pacific (Japan, China, India, and RoAPAC), and the Rest of the World (Latin America and Middle East & Africa)
• To profile the key players and comprehensively analyze their market shares and core competencies
• To track and analyze competitive developments such as product launches; agreements, partnerships,; mergers and acquisitions; and R&D activities in the market

More Information at http://www.rnrmarketresearch.com/contacts/purchase?rname=725677 .

The report covers the cold pain therapy market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the market in 2018.

Stakeholders
• Cold pain therapy product manufacturers
• Healthcare service providers
• Distributors and suppliers
• Research laboratories and academic institutes
• Original equipment manufacturers (OEMs)
• Market research companies

Get Discount on “Cold Pain Therapy Market by Product (OTC (Gels, Sprays, Patches, Cold Packs, Wraps, Pads, and Roll-Ons), Prescription-Based (Motorized, Non-Motorized Devices), Applications (Musculoskeletal Disorders, Post-Operative Therapy, Sports Medicine, and Post-Trauma Therapy) - Global Forecast to 2023” report @ http://www.rnrmarketresearch.com/contacts/discount?rname=725677 .

The OTC products segment accounted for the larger share of the global cold pain therapy market in 2017. This can be attributed to factors such as high patient preference for topical pharmaceuticals compared to oral medications owing to its lower side effects, fast pain relief, and convenience in use.

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, innovation and technology directors, and executives from various key organizations operating in the market.
• By Company Type: Tier I: 45%, Tier II: 34%, and Tier III: 21%
• By Designation: C-Level: 14%, Director-Level: 10%, and Others: 76%
• By Region: North America: 40%, Europe: 32%, APAC: 20%, and RoW: 8%

Contact:
sales@rnrmarketresearch.com / Call +1 888 391 5441
RnRMarketResearch Provides you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.

Mr. Hrishikesh
Tower B5, Office 101,
Magarpatta City SEZ,
Pune-411013, India

This release was published on openPR.